Platinum nanoparticles (PtNPs) are noteworthy scientific tools that are being explored in
various biotechnological, nanomedicinal, and pharmacological fields. They are unique …

The platinum drugs, cisplatin, carboplatin, and oxaliplatin, prevail in the treatment of cancer,
but new platinum agents have been very slow to enter the clinic. Recently, however, there …

The number of cancer survivors continues to increase due to the aging and growth of the
population and improvements in early detection and treatment. In order for the public health …

The health burden of cancer is increasing in China, with more than 1· 6 million people being
diagnosed and 1· 2 million people dying of the disease each year. As in most other …

Abstract Each year, the American Cancer Society estimates the numbers of new cancer
cases and deaths expected in the United States in the current year and compiles the most …

Breast cancer is the most common cancer in women in both developed and developing
countries and the second most common cancer in the world. Developing countries are …

This article challenges the idea that cancer cannot be prevented among older adults by
examining different aspects of the relationship between age and cancer. Although the …

Purpose To update guidance for health care providers about fertility preservation for adults
and children with cancer. Methods A systematic review of the literature published from …

The enhanced permeability and retention (EPR) of nanoparticles in tumors has long stood
as one of the fundamental principles of cancer drug delivery, holding the promise of safe …

Purpose To update the ASCO clinical practice guideline on adjuvant endocrine therapy on
the basis of emerging data on the optimal duration of treatment, particularly adjuvant …